Updated outcomes from the historical control study SCHOLAR-3 contextualizing ZUMA-3 results of brexucabtagene autoleucel (KTE-X19) in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL) Meeting Abstract


Authors: Shah, B. D.; Ghobadi, A.; Oluwole, O. O.; Logan, A. C.; Boissel, N.; Cassaday, R. D.; Leguay, T.; Bishop, M. R.; Topp, M. S.; Tzachanis, D.; O'Dwyer, K. M.; Arellano, M. L.; Lin, Y.; Baer, M. R.; Schiller, G. J.; Park, J. H.; Subklewe, M.; Abedi, M.; Minnema, M. C.; Wierda, W. G.; DeAngelo, D. J.; Stiff, P.; Jeyakumar, D.; Dong, J.; Adhikary, S.; Zhou, L.; Schuberth, P. C.; Faghmous, I.; Masouleh, B. K.; Houot, R.
Abstract Title: Updated outcomes from the historical control study SCHOLAR-3 contextualizing ZUMA-3 results of brexucabtagene autoleucel (KTE-X19) in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia (R/R B-ALL)
Meeting Title: 64th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 140
Issue: Suppl. 1
Meeting Dates: 2022 Dec 10-13
Meeting Location: New Orleans, LA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2022-11-15
Start Page: 3158
End Page: 3161
Language: English
ACCESSION: WOS:000893223203086
DOI: 10.1182/blood-2022-158248
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jae Hong Park
    356 Park